Venture investment in healthcare reached new heights in 2021, with more than $80 billion invested in biopharma, medical device, diagnostics/tools and healthtech companies, according to Silicon Valley Bank’s annual Healthcare Investments and Exits Report. The more than 30% increase over 2020’s record is punctuated by a banner first half of the year.
“Venture fundraising and investment in healthcare has continued at a torrid pace this year due to the great exit environment and lofty step ups in valuations,” said report author Jon Norris, Managing Director of SVB’s Life Science and Healthcare Practice. “With newly closed venture funds dedicated to healthcare this year, there is a large pool of capital to support new investments and create a well-funded venture healthcare ecosystem for years to come.”
SVB’s annual report analyzes and predicts trends for venture capital investing, fundraising and exits that shape the biopharma, medical device, diagnostics/tools and healthtech sectors in the US and Europe. Read more.
